| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
ABIONYX Pharma SA (PA: ABNX)
ABNX Technical Analysis
3
| As on 21st Nov 2024 ABNX STOCK Price closed @ 1.25 and we RECOMMEND Buy for LONG-TERM with Stoploss of 1.18 & Buy for SHORT-TERM with Stoploss of 1.22 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ABNXSTOCK Price
| Open | 1.30 | Change | Price | % |
| High | 1.30 | 1 Day | -0.04 | -3.10 |
| Low | 1.20 | 1 Week | -0.10 | -7.41 |
| Close | 1.25 | 1 Month | 0.02 | 1.63 |
| Volume | 49817 | 1 Year | -0.01 | -0.79 |
| 52 Week High 1.39 | 52 Week Low 0.92 | ||||
PA France Most Active Stocks
| ALNEV | 0.00 | % |
| FTI | 5.91 | -1.66% |
| VIEDS | 0.72 | 4.35% |
| ALVER | 0.00 | % |
| ATO | 0.16 | -15.79% |
| ALMAS | 0.01 | 0.00% |
| CGG | 0.69 | -2.82% |
| ALDRV | 0.00 | % |
| ELIOR | 2.75 | -11.86% |
| ALHYG | 0.01 | 0.00% |
PA France Top Gainers Stocks
PA France Top Losers Stocks
| ABNX Daily Charts |
ABNX Intraday Charts |
Whats New @ Bazaartrend |
ABNX Free Analysis |
|
|
ABNX Important Levels Intraday
| RESISTANCE | 1.44 |
| RESISTANCE | 1.38 |
| RESISTANCE | 1.34 |
| RESISTANCE | 1.30 |
| SUPPORT | 1.20 |
| SUPPORT | 1.16 |
| SUPPORT | 1.12 |
| SUPPORT | 1.06 |
ABNX Forecast November 2024
| 4th UP Forecast | 1.46 |
| 3rd UP Forecast | 1.39 |
| 2nd UP Forecast | 1.35 |
| 1st UP Forecast | 1.31 |
| 1st DOWN Forecast | 1.19 |
| 2nd DOWN Forecast | 1.15 |
| 3rd DOWN Forecast | 1.11 |
| 4th DOWN Forecast | 1.04 |
ABNX Weekly Forecast
| 4th UP Forecast | 1.38 |
| 3rd UP Forecast | 1.34 |
| 2nd UP Forecast | 1.31 |
| 1st UP Forecast | 1.29 |
| 1st DOWN Forecast | 1.21 |
| 2nd DOWN Forecast | 1.19 |
| 3rd DOWN Forecast | 1.16 |
| 4th DOWN Forecast | 1.12 |
ABNX Forecast2024
| 4th UP Forecast | 2.39 |
| 3rd UP Forecast | 2.02 |
| 2nd UP Forecast | 1.8 |
| 1st UP Forecast | 1.57 |
| 1st DOWN Forecast | 0.93 |
| 2nd DOWN Forecast | 0.7 |
| 3rd DOWN Forecast | 0.48 |
| 4th DOWN Forecast | 0.11 |
ABIONYX Pharma SA ( PA France Symbol : ABNX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ABNX Business Profile
ABIONYX Pharma SA, a biopharmaceutical company, discovers and develops high density lipoprotein (HDL) therapies for the treatment of cardiovascular and metabolic diseases. The company is developing a portfolio of HDL therapies, which include HDL mimetics for the rapid regression of atherosclerotic plaque in high-risk patients. It is developing CER-001, an engineered complex of recombinant human apoA-I, the structural protein of HDL, and phospholipids that is in Phase II clinical trials designed to mimicks the structural and functional biological properties of pre-beta HDL for the treatment of post-acute coronary syndrome patients and familial primary hypoalphalipoproteinemia patients; and CER-209, a drug candidate that is in Phase I clinical trial for the treatment of metabolic diseases in the liver, as well as atherosclerois and non-alcoholic steato-hepatitis. The company was formerly known as Cerenis Therapeutics Holding SA and changed its name to ABIONYX Pharma SA in August 2019. ABIONYX Pharma SA was founded in 2005 and is based in Labege, France. Address: 33-43 av. Georges Pompidou ? Bât. D2, Labege, France, 31130
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service